GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 36 filers reported holding GT BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,055 | -22.7% | 50,000 | 0.0% | 0.00% | – |
Q2 2023 | $15,600 | -43.3% | 50,000 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $27,500 | -38.9% | 50,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $45,000 | -48.9% | 50,000 | 0.0% | 0.00% | -66.7% |
Q3 2022 | $88,000 | -2.2% | 50,000 | +66.7% | 0.00% | +50.0% |
Q2 2022 | $90,000 | +4.7% | 30,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $86,000 | -6.5% | 30,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $92,000 | -8.9% | 30,000 | +100.0% | 0.00% | 0.0% |
Q3 2021 | $101,000 | -56.7% | 15,000 | 0.0% | 0.00% | -60.0% |
Q2 2021 | $233,000 | – | 15,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Silverleafe Capital Partners, LLC | 105,000 | $708,000 | 0.28% |
Welch Group, LLC | 10,000 | $67,000 | 0.01% |
Cubist Systematic Strategies, LLC | 33,703 | $227,000 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 14,260 | $96,000 | 0.00% |
Compagnie Lombard Odier SCmA | 15,000 | $101,000 | 0.00% |
ExodusPoint Capital Management, LP | 22,200 | $150,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 162,823 | $1,097,000 | 0.00% |
TWO SIGMA ADVISERS, LP | 51,100 | $344,000 | 0.00% |
TimeScale Financial, Inc. | 549 | $4,000 | 0.00% |
Hartford Financial Management Inc. | 500 | $3,000 | 0.00% |